BSECentuple Global Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Mon, 19 Jan, 2026 · 15:40 IST

Postal Ballot - Scrutinizer Report

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.0%Reaction day
₹129.10
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-2.7%+4.6% vs market
Pharmaceuticals peers, median of 157sector-2.1%+4.1% vs sector

On the reaction day the stock moved 4.6 pts more than Nifty Microcap 250 and 4.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.0-2.7+4.6-2.1+4.1
Next day
-0.0-3.5+3.4-3.4+3.4
2d
-2.0-2.0-0.1-2.0-0.0
3d
-4.0-4.1+0.1-3.2-0.7
4d
-5.8-3.9-1.9-3.5-2.4
5d
-4.0-2.0-2.0-3.2-0.8
1w
-7.7-0.6-7.2-2.2-5.6
15d
-22.9+4.4-27.4+1.1-24.1
1m
-34.2+1.3-35.5-1.5-32.7
2m
-57.6-6.9-50.8-7.9-49.8
3m
-50.5+4.6-55.2-0.1-50.4
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Checkpoint Trends Limited (formerly likely linked to 'Rubra' brand based on company email and website) conducted a postal ballot through e-voting between December 19, 2025 and January 17, 2026, with nine resolutions voted on. All nine resolutions were approved overwhelmingly with 99.88% votes in favor (968,361 shares) versus just 0.12% against (1,154 shares). Key resolutions included increasing authorized share capital, re-designating Mr. Shubham Chaudhary as Managing Director and CFO, appointing Mr. Anubhav Kumar Upadhyay as Whole Time Director, appointing Mr. Gunjan Gangwal as Non-Executive Independent Director, changing the company name, and increasing borrowing and foreign investment limits. The scrutinizer NVB & Associates confirmed the results were valid.

Likely market impact

Shareholders have approved a major restructuring package including capital expansion, board changes, and relaxed foreign investment limits, signaling potential fundraising or expansion plans ahead. The nearly unanimous approval (only 8 dissenting voters) suggests strong promoter control, which could also be a governance watchpoint for minority shareholders.